维普中文期刊产品整合服务
19篇 您的检索式:作者名="esi M"
    题名 作者 年代 出处 被引量
1Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease 显示文摘Toprak O Cirit M Esi E 2006Catheter Cardiovasc Interv2006,67,2:1
2Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease显示文摘Toprak O Cirit M Esi E 2006Catheterization and Cardiovascular Interventions2006,67,:1
3Recent knowledge on molecular components of lewy bodies discloses future therapeutic strategies in Parkinson's disease显示文摘Fornai F Lenzi P C esi M 2003Curt Drug Targets CNS Neurol Disord2003,2,3:1
4Hyperuricemia as a risk factor for contrast-induced nephmpathy in patients with chronic kidney disease 显示文摘Toprak O Cirit M Esi E 2006Catheter Cardiovase Interv2006,67,2:1
5Hyperurieemia as a risk factor for contrast-induced nehropathy in patients with chronic kidney disease显示文摘Toprak O Cirit M Esi F 0,,02:1
6Bond-slipinreinforced concrete elem ents 显示文摘LU CCIO N I B M LO PEZ D E D A N ESI R F 2005Journal of StructuralE ngineering2005,131,11:1
7The role of different chemicalmodifications of superoxide dismutase in preventing a prolonged muscu-lar ischemia/repe rfusion injury显示文摘Gia rdino R Giavar esi G Fini M 2002Ar tif Cells Blood Substit ImmobilBiotechnol2002,30,3:1
8The role of different chemical modifications of superoxide dismutase in preventing a prolonged muscular is chemia/reperfusion injury显示文摘Gia rdino R Giavar esi G Fini M 0,,03:1
9Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease 显示文摘TOPRAK O CIRIT M ESI E 2006Catheter Cardiovasc Interv2006,67,2:1
10Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease显示文摘Toprak O Cirit M Esi F 2006Catheter Cardiovasc In- terv2006,67,2:1
11Hyperuricemia as a risk factor-induced nephropathy in patients with chronic kidney disease显示文摘Toprak O Cirit M Esi E 2006Catheter cardiovasc Interv2006,68,1:1
12Hypemricemia as a risk factor for contrast- induced nephropathy in patients with chronic kidney disease显示文摘Toprak O Cirit M Esi E 2006Catheter Cardiovasc Interv2006,67,2:1
13Energy cost of walking measurements in subjects with lower limb amputations:a comparison study between floor and treadmil test显示文摘Trabal esi M Porcacchia P Averna T 0,,01:1
14Energy cost of walking measurements in subjects with lower limb amputations:a comparison study between floor and treadmil test显示文摘Trabal esi M Porcacchia P Averna T 0,,01:1
15The role of different chemical modifications of superoxide dismutase in preventing a prolonged muscular ischemia/reperfusion injury 显示文摘Gia rdino R Giavar esi G Fini M 2002Artif Cells Blood Substit Immobil Biotechnol2002,30,3:1
16Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease 显示文摘Toprak O Cirit M Esi E 2006Catheter Cardiovascular Interv2006,67,2:1
17Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease显示文摘Toprak O Cirit M Esi F 2006Catheter Cardiovasc Interv2006,67,2:1
18Hyperuricemia as a risk factor f or contrast - induced nephropathy in patients with chronic kidney dis- ease 显示文摘Toprak O Cirit M Esi E 2006Catheter Cardiovasc lnterv2006,67,:1
19Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease显示文摘TOPRAK O CIRIT M ESI E 2006Catheter Cardiovasc Interv2006,67,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费